Eric Lefkofsky, Getty

December 11, 2020 10:54 AM ESTUpdated December 14, 12:19 PM

Marrying precision med and AI, Groupon co-founder Eric Lefkofsky takes total haul for his analytics firm over the $1B line

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Regeneron makes $80M obesity deal with Hansoh

MIT scientists’ AI model one-ups AlphaFold 3, takes on ‘fundamental issue’ in drug R&D

Is there still hope for Summit's cancer drug buried in the data?

Updated: Omada Health rose 21% in its public market debut

EMA considers serious eye condition a ‘very rare’ side effect of semaglutide

sponsored

Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy ...